| Session Introduction | |||||
|
Tue4 Oct11:05am(5 mins)
|
|
Chris Herring |
|
Claire Dobson | |
|
Room: Auditorium 3
|
|||||
| TCR Evolution, revolution: How Adaptimmune is developing innovative TCR T-cell therapies to treat solid tumors | |||||
|
Tue4 Oct11:10am(30 mins)
|
|
Dr Jo Brewer | |||
|
Room: Auditorium 3
|
|||||
| The journey from discovery to therapy begins with a single cell | |||||
|
Tue4 Oct11:40am(30 mins)
|
|
Stephen Hague | |||
|
Room: Auditorium 3
|
|||||
| Automating high-throughput NGS and qPCR assays: Meet the Biomark™ X and the Juno™ | |||||
|
Tue4 Oct12:40pm(5 mins)
|
|
James Curtis | |||
|
Room: Auditorium 3
|
|||||
| Pin-point™ – A Modular Base Editing System Driving Cell and Gene therapies | |||||
|
Tue4 Oct02:00pm(30 mins)
|
|
Dr Michael Anbar | |||
|
Room: Auditorium 3
|
|||||
| Assist Plus Pipetting Platform | |||||
|
Tue4 Oct02:30pm(5 mins)
|
|
Ms Sharon Barnard | |||
|
Room: Auditorium 3
|
|||||
| Bioluminescent assay tools for TCR-T and CAR-T development and characterisation | |||||
|
Tue4 Oct02:35pm(5 mins)
|
|
Dr Craig Malcolm | |||
|
Room: Auditorium 3
|
|||||
| Armouring CAR-T cells therapy against the immunosuppressive microenvironment in solid tumour | |||||
|
Tue4 Oct02:40pm(30 mins)
|
|
Dr Romain Lara | |||
|
Room: Auditorium 3
|
|||||
| The impact of not understanding the genetic landscape, Ignorance will cost you time and money. | |||||
|
Tue4 Oct04:15pm(15 mins)
|
|
Melanie Maerken | |||
|
Room: Auditorium 3
|
|||||
| Next Generation Platforms for Human Gene Therapy | |||||
|
Tue4 Oct04:30pm(30 mins)
|
|
Prof Aravind Asokan | |||
|
Room: Auditorium 3
|
|||||
